Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.32 USD | +2.81% | -11.17% | +60.88% |
May. 09 | Larimar Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Zafgen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.88% | 467M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.88% | 21.93B | |
-12.15% | 22.34B | |
-5.29% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Larimar Therapeutics Gets US Patent Providing Extended Protection for CTI-1601 Through at Least 2040